CD19 chimeric antigen receptor T-cell therapy following autologous stem cell transplantation against relapsed or refractory Burkitt lymphoma/leukemia: A case report and literature review

Burkitt lymphoma or leukemia (BL) is a highly aggressive non-Hodgkin lymphoma. Older age (over 60 years old) and the presence of high-risk factors (such as abdominal mass, high levels of the serum lactic dehydrogenase, Ann Arbor stage II-IV and so on) usually predict a poorer outcome. Chimeric antig...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Mingyu, Gao, Lei, Wang, Tao, Yu, Jiechen, Gui, Jiaping, Yang, Jianmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639856/
https://www.ncbi.nlm.nih.gov/pubmed/36353549
http://dx.doi.org/10.3389/fonc.2022.932254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639856/
https://www.ncbi.nlm.nih.gov/pubmed/36353549
http://dx.doi.org/10.3389/fonc.2022.932254

Ejemplares similares